Himalaya Nutravedics India Limited disclosed that Himalaya Global Holdings Ltd. and M/s. Himalaya Wellness Company have filed a commercial suit against it, alleging trademark infringement and seeking damages of ₹2,00,01,000.

The plaintiffs also sought a direction for the company to change its corporate name to remove the word "HIMALAYA" and an injunction restraining the use of the mark "HIMALAYA NUTRAVEDICS". The suit was filed before the Hon'ble Additional District and Sessions Judge (Dedicated Commercial Court), Bengaluru Rural.

Nature of Allegations and Reliefs Sought

The plaintiffs allege that the company's use of the mark "HIMALAYA NUTRAVEDICS" on its goods and the word "HIMALAYA" in its corporate name infringes their registered trade mark. They claim the company operates in the pharmaceutical, nutraceutical, and Ayurvedic segment, overlapping with their business, and that this adoption is dishonest and causes consumer confusion.

The specific reliefs sought by the plaintiffs include:

• Permanent injunctions restraining the company from dealing in goods or services under the mark "HIMALAYA NUTRAVEDICS" or any deceptively similar mark.
• A direction to apply to the Registrar of Companies for a change of corporate name to remove the word "HIMALAYA".
• Damages valued at ₹2,00,01,000 together with costs.
• Delivery up for erasure or destruction of goods and material bearing the impugned mark.
• Rendition of accounts of profits from June 16, 2022, till the disposal of the suit.

Procedural History and Current Status

The company received intimation of the filing via email from the plaintiffs' advocates on October 3, 2026. The suit was e-filed on October 2, 2026, and physically filed on October 3, 2026, assigned Filing/Registration No. F.R. No. 437 of 2026. It is likely to be listed before the court on October 5, 2026.

This litigation follows a previous suit instituted by the same plaintiffs before the Hon'ble High Court of Delhi (CS(COMM) No. 1061/2026). By order dated September 28, 2026, the High Court ordered the return of the plaint with liberty to present it before the appropriate forum, leading to the current filing in Bengaluru.

Litigation Details

What the Numbers Show

The financial implications are currently unquantified beyond the stated damages claim of ₹2,00,01,000. However, the demand for rendition of accounts from June 16, 2022, introduces a variable liability dependent on the company's profit generation during that period. The company denies the allegations and states it will contest the suit, noting that no order has been passed against it as of the disclosure date.

Himalaya Nutravedics India Limited reported a 231.1% jump in Profit After Tax (PAT) for FY26, reaching ₹739.0 lakh. The integrated ayurvedic and nutraceutical company saw its top line more than double, driven by a strategic shift toward high-margin own-brand products.

Revenue from operations stood at ₹4,306.8 lakh, marking a 105.1% year-on-year increase from ₹2,099.7 lakh in FY25. EBITDA rose 171.0% to ₹810.3 lakh, with margins expanding by 458 basis points to 18.8%. The company’s return on equity (ROE) improved significantly to 63.9%, up 885 basis points from the previous year.

Financial Performance Overview

The company’s financial trajectory shows robust growth across key metrics over the last three fiscal years. The following table details the income statement highlights:

Business Mix Shift

A pivotal driver of the margin expansion was the change in revenue composition. Own-brand business contributions surged to 51.1% of total revenue in FY26, up from 19.7% in FY25. This shift reduced reliance on third-party contract manufacturing, which now accounts for 48.9% of the mix. The company’s product portfolio remains heavily weighted toward ayurvedic formulations, which constituted 94.6% of revenue in FY26.

Geographically, while Kerala remains an anchor market at 49.3%, the company has diversified its footprint. Gujarat contributed 13.2% and Uttar Pradesh 11.7% to FY26 revenues, reflecting successful expansion into new states.

What the Numbers Show

Despite the strong profit growth, cash flow from operations remained negative at ₹383.4 lakh in FY26, compared to ₹139.1 lakh in FY25. This divergence between rising profits and negative operating cash flow is linked to working capital dynamics. Trade receivables increased sharply to ₹1,058.7 lakh in FY26 from ₹564.0 lakh in FY25, indicating that a significant portion of the revenue growth is yet to be converted into cash. Additionally, inventory levels rose to ₹891.5 lakh, suggesting potential buildup ahead of planned distribution expansions.

Strategic Outlook

The company plans to deploy ₹750.00 lakh from net proceeds toward branding and digital marketing to support its transition to a direct-to-consumer (D2C) model. This initiative aims to capture impulse-led demand through e-commerce and quick commerce platforms, complementing its existing practitioner-driven offline sales network.